Clark Capital Management Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$510K Buy
1,449
+122
+9% +$43.5K ﹤0.01% 384
2025
Q4
$434K Buy
1,327
+224
+20% +$71.1K ﹤0.01% 375
2025
Q3
$311K Buy
1,103
+182
+20% +$52.8K ﹤0.01% 389
2025
Q2
$257K Sell
921
-87
-9% -$24.6K ﹤0.01% 387
2025
Q1
$314K Sell
1,008
-255
-20% -$75.3K ﹤0.01% 375
2024
Q4
$329K Sell
1,263
-121,340
-99% -$36M ﹤0.01% 364
2024
Q3
$39.5M Buy
122,603
+2,362
+2% +$773K 0.27% 114
2024
Q2
$37.6M Buy
120,241
+1,838
+2% +$540K 0.28% 113
2024
Q1
$33.7M Sell
118,403
-90,535
-43% -$26.5M 0.25% 130
2023
Q4
$60.2M Buy
+208,938
New +$56.9M 0.49% 54
2020
Q4
Sell
-71,755
Closed -$18.2M 341
2020
Q3
$18.2M Sell
71,755
-3,395
-5% -$841K 0.34% 123
2020
Q2
$17.7M Sell
75,150
-1,224
-2% -$279K 0.33% 122
2020
Q1
$15.5M Sell
76,374
-28,524
-27% -$6.23M 0.39% 104
2019
Q4
$25.3M Sell
104,898
-2,073
-2% -$457K 0.53% 64
2019
Q3
$20.7M Buy
106,971
+881
+0.8% +$169K 0.47% 87
2019
Q2
$19.6M Buy
106,090
+6,764
+7% +$1.21M 0.41% 92
2019
Q1
$18.9M Sell
99,326
-78,721
-44% -$15M 0.45% 91
2018
Q4
$34.7M Sell
178,047
-40,277
-18% -$7.86M 0.93% 33
2018
Q3
$45.3M Buy
218,324
+43,901
+25% +$8.65M 1.15% 20
2018
Q2
$32.2M Buy
174,423
+12,674
+8% +$2.24M 0.93% 32
2018
Q1
$27.6M Buy
161,749
+45,642
+39% +$8.38M 0.86% 36
2017
Q4
$20.2M Sell
116,107
-24,621
-17% -$4.36M 0.62% 60
2017
Q3
$26.2M Buy
140,728
+36,865
+35% +$6.53M 0.88% 31
2017
Q2
$17.9M Buy
103,863
+11,192
+12% +$1.82M 0.7% 41
2017
Q1
$15.2M Sell
92,671
-63,821
-41% -$10.6M 0.67% 47
2016
Q4
$22.9M Buy
156,492
+19,831
+15% +$2.98M 1.19% 14
2016
Q3
$22.8M Buy
136,661
+12,399
+10% +$2.1M 1.31% 10
2016
Q2
$18.9M Buy
124,262
+22,286
+22% +$3.46M 1.22% 13
2016
Q1
$15.3M Buy
101,976
+40,718
+66% +$6.05M 1.18% 20
2015
Q4
$9.94M Buy
61,258
+5,801
+10% +$912K 0.81% 34
2015
Q3
$7.67M Sell
55,457
-10,034
-15% -$1.58M 0.68% 47
2015
Q2
$10.1M Buy
65,491
+1,019
+2% +$163K 0.92% 30
2015
Q1
$10.3M Buy
64,472
+5,636
+10% +$888K 0.94% 29
2014
Q4
$9.37M Buy
58,836
+4,196
+8% +$654K 0.86% 33
2014
Q3
$7.67M Buy
54,640
+2,223
+4% +$290K 0.66% 38
2014
Q2
$6.21M Sell
52,417
-3,436
-6% -$398K 0.52% 56
2014
Q1
$6.89M Buy
55,853
+43,920
+368% +$5.33M 0.59% 49
2013
Q4
$1.36M Sell
11,933
-580
-5% -$66K 0.11% 123
2013
Q3
$1.4M Sell
12,513
-7,101
-36% -$770K 0.11% 121
2013
Q2
$1.94M Buy
+19,614
New +$2.04M 0.18% 98

Other funds holding AMGN

Clark Capital Management Group's AMGN Position: Q1 2026 in Review

Clark Capital Management Group increased its Amgen (AMGN) stake by 9.2% in Q1 2026, buying an estimated $43.5K and bringing the position to 1,449 shares worth $510K. The position accounts for ﹤0.01% of the portfolio, ranked #384.

Clark Capital Management Group first reported a position in AMGN in Q2 2013 and has held it in 40 quarters since. The position peaked at $60.2M in Q4 2023. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Clark Capital Management Group held 1,449 shares of Amgen worth $510K as of Q1 2026.
  • Clark Capital Management Group bought 122 Amgen shares in Q1 2026, an estimated $43.5K.
  • Amgen made up ﹤0.01% of Clark Capital Management Group's portfolio in Q1 2026, its #384 holding.
  • Clark Capital Management Group first reported a position in Amgen in Q2 2013 and has held it in 40 quarters since.
  • Clark Capital Management Group's Amgen position peaked at $60.2M in Q4 2023.
  • 3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Clark Capital Management Group's 13F filing for Q1 2026, filed 15 May 2026.